title: High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
authors.forename: Helen J
authors.initials: HJ
authors.lastname: Lachmann
authors.forename: Ashutosh D
authors.initials: AD
authors.lastname: Wechalekar
authors.forename: Julian D
authors.initials: JD
authors.lastname: Gillmore
mesh_terms: D000686:Amyloidosis / Q000188:drug therapy* / Q000401:mortality; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D018380:Hematopoietic Stem Cell Transplantation / Q000401:mortality; D006801:Humans; D007147:Immunoglobulin Light Chains; D008558:Melphalan / Q000008:administration & dosage*; D019653:Myeloablative Agonists / Q000008:administration & dosage*
chemical_list: D007147:Immunoglobulin Light Chains; D019653:Myeloablative Agonists; D003907:Dexamethasone; D008558:Melphalan